Categories Earnings, Technology

Microchip joins the consolidation party of chipmakers

We had earlier reported that consolidation in the semiconductor industry appears to be the order of the day. Thanks to the increasing demands for new products, spiraling costs for setting up fabs, and increasing R&D costs, chipmakers are looking for M&As, which would help them diversify into new areas, enter new geographies and faster rollout of products.

Microchip Acquisition
Courtesy: Designed by xb100/Freepik

The latest to join the bandwagon was Microchip, which announced last week it’s plans to acquire its counterpart Microsemi for $8.35 billion. Microchip has agreed to pay $68.75 per share in cash to buy Microsemi, a transaction that would bring in saving of $300 million in the third year post the closing of the deal. The transaction will be completed in the second quarter of this year.

Microchip currently mulls expansion of its footprint in the aerospace and defense verticals post the deal. These two verticals currently contribute a paltry 2% to the chipmaker. The deal would also beef up its presence in the data center and communications domains, which is expected to witness strong growth, especially in the areas of autonomous driving, IoT and 5G networks in US.

In January 2017, KPMG in its Global Semiconductor Outlook stated that, “M&A continues to offer companies the fastest route to enter new markets and acquire needed technology.”

It’s worth noting that Broadcom wants to buy Qualcomm for $117 billion in a hostile bid, which is still ongoing. Qualcomm on its own is trying to gobble up NXP Semiconductors for $44 billion.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top